Latest News for: azn

Edit

The $80 Billion Ambition: An In-Depth Analysis of AstraZeneca (AZN) in 2026

The Call 10 Feb 2026
AZN; LSE. AZN) stands today at a critical crossroads of pharmaceutical history ... As of February 2026, AZN has delivered a total price return of approximately 325.7%, significantly outperforming the FTSE 100 and its primary UK rival, GSK.
  • 1

Article Search

tools
×
×
×
×